Heart failure results not only from cardiac overload or injury but also from a complex
interplay among genetic, neurohormonal, inflammatory, and biochemical changes acting on
cardiac myocytes, the cardiac interstitium, or both. This review focuses on biomarkers for
heart failure other than routinely determined laboratory values and discusses how these
might be used in assessing and managing heart failure.